| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO (interim)
2 companies
Downs Christopher is a Chief Financial Officer at CNS Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $808K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CNSP Cns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 66,666 | $0.30 | $19,999.80 | +181.3% | -13.7% | -99.2% | |
| Aug 22, 2023 | CNSP Cns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 27,000 | $1.27 | $34,176.60 | +276.3% | +41.4% | -99.8% | |
| Apr 17, 2023 | CNSP Cns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 3,100 | $3.20 | $9,920.00 | +50.4% | -22.2% | -92.4% | |
| Dec 6, 2021 | CNSP Cns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 5,000 | $0.94 | $4,701.50 | +3.4% | -71.7% | -91.1% | |
| Nov 19, 2021 | CNSP Cns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 4,500 | $1.15 | $5,191.65 | +3.2% | -70.9% | -82.5% | |
| Aug 24, 2020 | CNSP Cns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 142,000 | $2.04 | $289,680.00 | New | - | - | |
| Aug 14, 2017 | INFU Infusystem Holdings, Inc | CFO (interim) | Buy | 7,900 | $1.90 | $15,010.00 | +37.7% | - | - |